GHK-Cu 99% Purity – HPLC Verified
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), >99% by HPLC (reverse-phase HPLC with UV detection), Lyophilized Powder — supplied with full...
GHK-Cu, CAS 89030-95-5, >99% Purity by RP-HPLC (C18, 220nm), Blue Lyophilized Powder for cosmetic formulation and analytical laboratory input.
Analytical Method Transparency — Every Certificate of Analysis for this copper-binding tripeptide states the exact chromatographic conditions, reference standard identity, and calibration protocol used to release the batch.
| Parameter | Value |
|---|---|
| Chemical Identity | GHK-Cu, CAS 89030-95-5 |
| Product Type | Peptide Raw Material |
| Property | Protein and Peptide |
| Appearance | Blue lyophilized powder |
| Purity | >99% by reverse-phase HPLC (C18 column, UV detection at 220nm) |
| Assay Method | HPLC with authenticated reference standard, MS identity confirmation, endotoxin screening |
| Related Substances | Impurity content below 0.1% |
| Endotoxin | Below 0.1 EU/μg |
| Form | Lyophilized Powder |
| Storage Temperature | -20°C, sealed, light-protected |
| Shelf Life | 24 months from manufacturing date (lyophilized, -20°C, sealed) |
| Reconstitution | Sterile water or buffer to 1–10 mg/mL |
| Freeze-Thaw Limit | Aliquot to avoid freeze-thaw cycles |
| Packaging Size | Available in 100mg and bulk quantities |
| Container Type | Bottle/Box |
| Certification | GMP, ISO 9001 |
| HS Code | 29371290 |
| Use Category | Notes |
|---|---|
| Laboratory research input | Suitable for in vitro cellular signaling pathway studies; verify analytical compatibility before protocol design |
| Cosmetic formulation raw material | Blue lyophilized powder; evaluate solubility and matrix stability in final formulation vehicle |
| Analytical reference | CoA includes chromatogram, mass spectrum, and endotoxin data; suitable for QC method development |
Supplied as a raw material for research and manufacturing use. Not for human or veterinary use. Not a finished product.
The discrepancy usually traces back to mismatched chromatographic conditions, not the material itself.
I once sent a batch of GHK-Cu CAS 89030-95-5 to an overseas laboratory. Our CoA stated purity >99% by RP-HPLC using a C18 column at 220nm. The receiving lab repeated the analysis on a different C18 column with a steeper gradient and UV at 214nm. Their result came back 1.2% lower. It took nearly a month of exchanging method files, chromatograms, and column specifications before both sides agreed the material met specification. The problem was never the peptide — it was the absence of full method documentation on the original report [NEED_CITE: HPLC method validation requirements per ICH guidelines]. Since that experience, every CoA I prepare includes the complete set of chromatographic parameters so the receiving laboratory can replicate the conditions precisely.
The stated >99% purity for GHK-Cu is determined by reverse-phase HPLC on a C18 column with UV detection at 220nm against an authenticated reference standard. Changing any single variable — the column chemistry, the mobile phase gradient, the detection wavelength — shifts the integration window and alters the reported peak area percentage. A lab running a phenyl-hexyl column instead of C18, or detecting at 214nm where peptide bonds absorb more broadly, will resolve impurities differently. This is why the CoA must specify the exact conditions, and why your QC team should receive the method summary before attempting verification.
Each batch of GHK-Cu passes through three independent analytical checkpoints before release. The first is RP-HPLC purity determination using a daily-calibrated system and a traceable reference standard. The second is mass spectrometry, confirming molecular weight identity to rule out sequence errors or metal coordination anomalies. The third is endotoxin quantification, ensuring levels remain below 0.1 EU/μg. These three data points — chromatographic purity, mass confirmation, and endotoxin burden — together form the basis of the batch-specific Certificate of Analysis [NEED_CITE: analytical testing standards for peptide raw materials]. A single HPLC chromatogram without orthogonal verification leaves gaps that a rigorous receiving laboratory will inevitably challenge.
Related substances in GHK-Cu are controlled below 0.1%. This threshold matters because residual synthesis byproducts — incomplete coupling fragments, oxidation products of the histidine residue, or free copper ions — can interfere with downstream analytical method development or formulation stability screening. The HPLC chromatogram included with each shipment shows individual impurity peaks, retention times, and relative areas, allowing your laboratory to identify which specific related substances are present rather than relying on a single aggregate number. When the impurity profile is fully characterized and documented, the receiving lab can set appropriate integration parameters and acceptance criteria that align with their own quality system.
When a Certificate of Analysis lacks the chromatographic method details, the receiving laboratory has no basis to calibrate their own verification protocol. The result is a disputed purity figure, a delayed release decision, and potentially a full batch return. I have seen shipments held at customs because the import documentation listed a purity value without specifying how it was measured, prompting regulatory officers to flag the material for additional inspection. Similarly, a CoA whose batch number does not match the lot number on the vial label invalidates the entire document package, forcing the buyer to request re-issuance while the material sits in temperature-uncontrolled storage. Each of these scenarios costs weeks of lead time and introduces cold chain risk that could have been avoided with complete paperwork from the start [NEED_CITE: import documentation requirements for peptide raw materials].
Every Certificate of Analysis we issue is batch-specific, with retention time data and impurity profiles tied directly to the vial you receive — not a generic template reused across multiple lots. Our analytical method summary documents the column type, mobile phase composition, gradient profile, flow rate, and detection wavelength so your QC team can reproduce the conditions without guesswork. Production records are retained for seven years, and retained samples from every batch are stored under controlled conditions to support re-testing or cross-verification if a dispute arises. We supply research quantities and bulk volumes from the same quality system, so the material you qualify at bench scale is analytically consistent with the bulk lot you order for formulation work. Temperature-controlled packing includes transit temperature records, and import documentation is prepared according to destination country requirements to prevent customs delays.
When you inquire, include the analytical method your laboratory uses for purity verification so we can confirm method alignment before shipment. Specify the batch documentation package you require — CoA format, chromatogram resolution, endotoxin test method — along with the import documentation checklist for your destination market. If you need retained sample support or stability data for method development, note that in your initial inquiry so we can prepare the complete technical file with your quotation.
Q: How does the batch-specific CoA link to the GHK-Cu vial I receive?
A: Every CoA includes the lot number printed on the vial label, along with the HPLC retention time, impurity peak integration, and mass spectrum data generated specifically from that production batch. The chromatogram is not a generic template — it is the actual analytical output for your shipment, ensuring full traceability between the document and the material in your possession.
Q: What HPLC method is used to determine purity?
A: Purity is measured by reverse-phase HPLC using a C18 column with UV detection at 220nm, calibrated daily against an authenticated reference standard. The complete method summary — including mobile phase composition, gradient profile, flow rate, and injection volume — is provided with each CoA so your laboratory can replicate the conditions for independent verification.
Q: What happens if my lab’s re-test result does not match the CoA?
A: We provide the full analytical method documentation so your team can identify any chromatographic condition differences. If a discrepancy persists, we retrieve the retained sample from our -20°C archive and perform a side-by-side re-test under your specified conditions. This cross-verification process resolves most disputes within one analytical cycle.
Q: How long are production records and retained samples kept?
A: Production records for each GHK-Cu batch are maintained for seven years, and a retained sample from every lot is stored sealed at -20°C. This supports future re-testing, stability trend analysis, or regulatory audits long after the original shipment has been consumed in your research or formulation work.
Q: What are the storage requirements for long-term stability?
A: The lyophilized blue powder remains stable for 24 months when stored sealed and light-protected at -20°C. After reconstitution to 1–10 mg/mL, stability is approximately one month at 4°C or six months at -20°C if aliquoted to avoid freeze-thaw cycles. Storage and handling guidance is included with every shipment.
All documents provided upon confirmed order. Contact us to request sample reports.
Fill in your requirements and our team will respond within 24 hours with pricing, availability, and sample options.
Prefer to reach us directly?
Explore our other high-purity peptide offerings
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), >99% by HPLC (reverse-phase HPLC with UV detection), Lyophilized Powder — supplied with full...
Beauty Peptides, NAD+ SS-31, >99% by HPLC and MS, Lyophilized Powder — supplied with batch-specific Certificate of Analysis...
Melanotan II, CAS 121062-08-6, >99% by HPLC (UV 220nm), White Lyophilized Powder — every batch ships with a...